tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pelthos Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlyPelthos Therapeutics initiated with an Outperform at Oppenheimer
2M ago
Premium
Company Announcements
Pelthos Therapeutics Completes Merger with Channel Therapeutics
3M ago
Pelthos Therapeutics reports Q2 EPS ($5.38) vs ($3.07) last year
Premium
The Fly
Pelthos Therapeutics reports Q2 EPS ($5.38) vs ($3.07) last year
3M ago
Pelthos Therapeutics target adjusted at Alliance after merger, reverse split
PremiumThe FlyPelthos Therapeutics target adjusted at Alliance after merger, reverse split
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100